Classification specific lymphatic malformations management on head and neck in children

Oral Surg Oral Med Oral Pathol Oral Radiol. 2023 Apr;135(4):e74-e82. doi: 10.1016/j.oooo.2022.09.001. Epub 2022 Sep 9.

Abstract

Objective: The aim of this study was to retrospectively analyze the outcomes from surgical and nonsurgical treatments for head and neck lymphatic malformations (LMs) in children.

Study design: Fifty-eight patients were divided into a surgical group (22) and a nonsurgical group (36). The surgical group contained microcystic LMs in the tongue treated by surgery or with sclerotherapy. The nonsurgical group contained macrocystic and mixed LMs in floor of the mouth, neck, face, submandibular region, maxillofacial region and neck treated by sclerotherapy or with microwave ablation (MWA).

Results: In the surgical group, the mean follow-up time was 44 ± 15.3 months. At last follow-up, 15 LMs (68.2%) were completely controlled, 3 LMs (13.6%) were stable without need for further treatment, and 4 LMs (18.2%) were persistent. In the nonsurgical group, the median follow-up time was 23.5 months (13.0, 32.8). At last follow-up, 28 LMs (77.8%,) have a volume reduction rate of >50%, and 6 LMs (16.7%.) have the complication.

Conclusions: Surgery is suitable for microcystic LMs in the early stage with clear boundary and becomes limited for them in the late stages due to diffuse lesions. Sclerotherapy is effective for macrocystic and mixed LMs. Sclerotherapy with MWA is exceptionally effective for large cystic LMs with multiple compartments.

MeSH terms

  • Child
  • Head*
  • Humans
  • Infant
  • Lymphatic Abnormalities* / pathology
  • Lymphatic Abnormalities* / surgery
  • Neck
  • Retrospective Studies
  • Sclerotherapy
  • Treatment Outcome